GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

The results of the most recent study are disappointing. But the researchers have proposed more studies to explore similar drugs that may reach other targets in the brain. The potential for GLP-1 drugs ...

In recent years, weight-loss drugs have become a common addition to diet and exercise routines. The rise of GLP-1 medications ...

In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices ...

Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more ...

That was just the start of it. Fourteen months after starting Zepbound ― an injectable GLP-1 medication for weight loss ― ...

A large retrospective cohort study of adult female breast cancer patients found that GLP-1 receptor agonist use was ...

GLP-1 use isn't just drastically changing the lives of those, like McDonald, who are on the weight-loss drug. It's changing ...

In the latest effort by the Trump administration to reduce costs and increase access to anti-obesity medications like Ozempic ...